UroGen Pharma
Developing RTGel drug technology
- B2B
About UroGen Pharma
Innovative biotech company developing novel solutions using RTGel technology for specialty cancers and urologic diseases, with a collaborative drive for bold results
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Princeton, New Jersey, United States
- Founded
- 2004
- Revenue
- $110MFY2025, publicly reported
- Website
- urogen.com
UroGen Pharma at a glance
UroGen Pharma is a B2B company in the Biotechnology Research industry, headquartered in Princeton, New Jersey, United States.
UroGen Pharma was founded in 2004.
UroGen Pharma has 251–1,000 employees.
UroGen Pharma's revenue is $110M (FY2025, publicly reported).
Selling to companies like UroGen Pharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies